Commonly Prescribed Diabetes Drug, Onglyza, Linked to an Increased Risk of Cancer, Heart Failure, and Death
What is Onglyza?
Onglyza is an anti-diabetic medication manufactured by Astra Zeneca and their former partner, Bristol-Meyers Squibb. Onglyza was designed to control blood sugar levels in type 2 diabetes patients and is often used in conjunction with diet and exercise. The active ingredient is saxagliptin which increases insulin secretion, slows down gastric emptying and decreases blood glucose levels.
Onglyza belongs to a class of medications referred to as incretin mimetics—a new group of drugs that help keep blood sugar within a target range without causing low blood sugar or weight gain.
Severe side-effects linked to Onglyza use include:
- Heart failure
- Pancreatic cancer
- Thyroid cancer
- Kidney problems
- Renal failure
Milder side-effects include:
- Allergic reactions—rashes/hives, breathing difficulty, swelling of the face, lips tongue and throat
- Muscle weakness or pain
- Joint pain
- Unintended weight loss or gain
- Pain in the upper stomach
- Loss of appetite
- Increased thirst
- Increased heart rate
- Dark urine
- Increased urination
- Pale Stools
Incretin Mimetics and the Possible Link to Dangerous Pancreatic Conditions
In March of 2013, the Federal Drug Administration (FDA) announced that it is investigating a link between incretin mimetic medications and pancreatic cancer.
Other incretin mimetics drugs include:
- Kombiglyze XR
Understand Your Legal Options
1-800-LAW-FIRM is at the forefront of any drug and medical device litigation you’ve seen advertised. If you or someone you love suffered heart failure or a cancer diagnosis after taking Onglyza, please contact the experienced legal team at 1-800-LAW-FIRM. There is no obligation and all calls are free. You may be entitled to a cash compensation. The time to file a claim is limited. Contact 1-800-LAW-FIRM and learn about your options today.